Type 2 diabetes and obesity induce similar transcriptional reprogramming in human myocytes

被引:33
|
作者
Varemo, Leif [1 ]
Henriksen, Tora Ida [2 ,3 ]
Scheele, Camilla [2 ,3 ,4 ]
Broholm, Christa [2 ,3 ]
Pedersen, Maria [2 ,3 ]
Uhlen, Mathias [5 ,6 ]
Pedersen, Bente Klarlund [2 ,3 ]
Nielsen, Jens [1 ,6 ]
机构
[1] Chalmers Univ Technol, Dept Biol & Biol Engn, S-41296 Gothenburg, Sweden
[2] Univ Copenhagen, Rigshosp, Ctr Inflammat & Metab, DK-2100 Copenhagen O, Denmark
[3] Univ Copenhagen, Rigshosp, Ctr Phys Act Res, DK-2100 Copenhagen O, Denmark
[4] Univ Copenhagen, Ctr Basic Metab Res, Novo Nordisk Fdn, DK-2200 Copenhagen N, Denmark
[5] AlbaNova Univ Ctr, Royal Inst Technol KTH, Sch Biotechnol, Dept Prote, S-10691 Stockholm, Sweden
[6] Royal Inst Technol KTH, Sci Life Lab, S-17121 Stockholm, Sweden
来源
GENOME MEDICINE | 2017年 / 9卷
基金
新加坡国家研究基金会;
关键词
Type; 2; diabetes; Obesity; Skeletal myocytes; RNA-seq; Gene expression; Gene-set analysis; Metabolic network; DIFFERENTIAL EXPRESSION ANALYSIS; HUMAN SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; INSULIN SENSITIVITY; METABOLIC SYNDROME; DEVELOPMENTAL REGULATORS; GENE-EXPRESSION; RESISTANCE; DEFECTS; NETWORK;
D O I
10.1186/s13073-017-0432-2
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Skeletal muscle is one of the primary tissues involved in the development of type 2 diabetes (T2D). The close association between obesity and T2D makes it difficult to isolate specific effects attributed to the disease alone. Therefore, here we set out to identify and characterize intrinsic properties of myocytes, associated independently with T2D or obesity. Methods: We generated and analyzed RNA-seq data from primary differentiated myotubes from 24 human subjects, using a factorial design (healthy/T2D and non-obese/obese), to determine the influence of each specific factor on genome-wide transcription. This setup enabled us to identify intrinsic properties, originating from muscle precursor cells and retained in the corresponding myocytes. Bioinformatic and statistical methods, including differential expression analysis, gene-set analysis, and metabolic network analysis, were used to characterize the different myocytes. Results: We found that the transcriptional program associated with obesity alone was strikingly similar to that induced specifically by T2D. We identified a candidate epigenetic mechanism, H3K27me3 histone methylation, mediating these transcriptional signatures. T2D and obesity were independently associated with dysregulated myogenesis, down-regulated muscle function, and up-regulation of inflammation and extracellular matrix components. Metabolic network analysis identified that in T2D but not obesity a specific metabolite subnetwork involved in sphingolipid metabolism was transcriptionally regulated. Conclusions: Our findings identify inherent characteristics in myocytes, as a memory of the in vivo phenotype, without the influence from a diabetic or obese extracellular environment, highlighting their importance in the development of T2D.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Type 2 diabetes and obesity induce similar transcriptional reprogramming in human myocytes
    Leif Väremo
    Tora Ida Henriksen
    Camilla Scheele
    Christa Broholm
    Maria Pedersen
    Mathias Uhlén
    Bente Klarlund Pedersen
    Jens Nielsen
    Genome Medicine, 9
  • [2] Human subcutaneous adipose tissue Glut 4 mRNA expression in obesity and type 2 diabetes
    Kouidhi, Soumaya
    Berrhouma, Rym
    Rouissi, Kamel
    Jarboui, Slim
    Clerget-Froidevaux, Marie-Stephanie
    Seugnet, Isabelle
    Bchir, Fattouma
    Demeneix, Barbara
    Guissouma, Hajer
    Elgaaied, Amel Benammar
    ACTA DIABETOLOGICA, 2013, 50 (02) : 227 - 232
  • [3] Mitochondrial alteration in type 2 diabetes and obesity An epigenetic link
    Cheng, Zhiyong
    Almeida, Fabio A.
    CELL CYCLE, 2014, 13 (06) : 890 - 897
  • [4] Epigenetics: spotlight on type 2 diabetes and obesity
    Desiderio, A.
    Spinelli, R.
    Ciccarelli, M.
    Nigro, C.
    Miele, C.
    Beguinot, F.
    Raciti, G. A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (10) : 1095 - 1103
  • [5] Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 Diabetes
    Zatterale, Federica
    Raciti, Gregory Alexander
    Prevenzano, Immacolata
    Leone, Alessia
    Campitelli, Michele
    De Rosa, Veronica
    Beguinot, Francesco
    Parrillo, Luca
    BIOMOLECULES, 2022, 12 (07)
  • [6] Chrononutrition in type 2 diabetes mellitus and obesity: A narrative review
    Verde, Ludovica
    Di Lorenzo, Tonia
    Savastano, Silvia
    Colao, Annamaria
    Barrea, Luigi
    Muscogiuri, Giovanna
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2024, 40 (02)
  • [7] Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes
    Bellini, Lara
    Campana, Melanie
    Mahfouz, Rana
    Carlier, Aurelie
    Veret, Julien
    Magnan, Christophe
    Hajduch, Eric
    Le Stunff, Herve
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (08) : 1037 - 1050
  • [8] Irisin is a predictor of sarcopenic obesity in type 2 diabetes mellitus A cross-sectional study
    Oguz, Ayten
    Sahin, Murat
    Tuzun, Dilek
    Kurutas, Ergul B.
    Ulgen, Cansu
    Bozkus, Ozlem
    Gul, Kamile
    MEDICINE, 2021, 100 (26)
  • [9] Dysregulation of Lipid Droplet Protein Expression in Adipose Tissues and Association with Metabolic Risk Factors in Adult Females with Obesity and Type 2 Diabetes
    Park, Chan Yoon
    Kim, Donguk
    Seo, Min Kyeong
    Kim, Jimin
    Choe, Han
    Kim, Jong-Hyeok
    Hong, Joon Pio
    Lee, Yeon Ji
    Heo, Yoonseok
    Kim, Hwa Jung
    Park, Hye Soon
    Jang, Yeon Jin
    JOURNAL OF NUTRITION, 2023, 153 (03) : 691 - 702
  • [10] Lifestyle and Genetics in Obesity and type 2 Diabetes
    Temelkova-Kurktschiev, T.
    Stefanov, T. S.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2012, 120 (01) : 1 - 6